Loading…
Loading…
Tender Value
Refer Docs
EMD Value
₹1.0 L
Closing Date
2 Jun 2026, 11:00 amClosed
Single Packet
Normal Tender
No
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Rly. Board
Expenditure
General
82
2 conditions · 1 needing a document upload
Procurement will be done only from Proprietary Article Certificate (PAC) firm i.e. M/s AstraZeneca Pharma India Ltd as per PAC certificate attached.
In keeping with the Public Procurement (Preference to Make in India) Order, 2017, as amended, and in terms of clause 2.4.2, 2.4.5 and 2.4.6 of Instructions to Tenderers Rev. 1.21 April 2024 (along with all its correction slips, if any), Public procurement of this item is restricted to Class - I and Class-II local suppliers only. Thus, only class-I and class-II local supplier as defined under the public procurement (Preference to Make in India) Order, 2017, as amended shall be eligible to bid in this tender. Offer from vendors who do not quality to be Class - I (Local Content: minimum 50%) or Class-II (Local Content: minimum 20% but less than 50%) local supplier, shall be summarily rejected and, therefore, such vendors should not participate in the tender. In case any vendor who does not qualify to be a Class - I or Class-II local supplier for the tendered item participates in the tender, such a bidder does so at its own risk and cost and Railways shall not be liable for any loss or damage caused to the bidder on this account. NOTE-1: - As per Public Procurement (Preference to Make in India) Order, 2017, procurements where the estimated value to be procured is less than Rs 5 lakhs shall be exempt from this Order. NOTE-2: - Items which are exempted under GTE list are also exempted from above criteria.
17 conditions
NOT APPLICABLE
In terms of clause as per Para 2.4.3 of Instruction to Tenderers regarding restrictions on procurement form a bidder of a country which shares a land border with India. I, hereby confirm that I have read the clause regarding restrictions on procurement form a bidder of a country which shares a land border with India and I certify that I am not from such a country.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
1 location across Delhi · 40 Numbers total
AMI No.Gr.16.N.08/2026-27 Inj Trastuzumab Deruxtecan 100mg
82269944A
82269944A
Open - Indigenous
Goods
Delhi
₹0
₹1.0 L
2 Jun 2026
8 May 2026
1 item · 40 Numbers total
AMI No.Gr.16.N.08/2026-27 Inj Trastuzumab Deruxtecan 100mg [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitt ed: Max 8 lacs ] ]
| Delivery Location | State | Quantity |
|---|---|---|
| NR Central Hospital, NR | Delhi | 40.00 Numbers |
| Total | 40 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5615615.pdf
ATTACHMENT
5766126.pdf
ATTACHMENT
5615616.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .